1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
About Regenerative Medicine
Regenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.
The analysts forecast the global regenerative medicine market to grow at a CAGR of 18.96% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
The report, Global Regenerative Medicine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Market drivers
Market challenges
Market trends
Key questions answered in this report
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Regenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.
The analysts forecast the global regenerative medicine market to grow at a CAGR of 18.96% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
The report, Global Regenerative Medicine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
Market drivers
- Increasing prevalence of chronic diseases
- For a full, detailed list, view the full report
Market challenges
- Uncertain regulatory approval
- For a full, detailed list, view the full report
Market trends
- Emerging technological advances
- For a full, detailed list, view the full report
Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGYPART 11: DECISION FRAMEWORK
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY TECHNOLOGY
PART 08: MARKET SEGMENTATION BY APPLICATION
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
New Report Released: - Global Regenerative Medicine Market 2018-2022.
The author of the report recognizes the following companies as the key players in the global regenerative medicine market: ALLERGAN, Integra LifeSciences, Medtronic, MiMedx Group, Organogenesis, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “One trend in the market is emerging technological advances. With the growing demand, vendors in the stem cell therapy market focus on investing in technological advancements such as using regenerated tracheas for transplant and 3D bioprinting to survive in this competitive market.”
According to the report, one driver in the market is increasing prevalence of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US had one of more chronic health conditions in 2012. Moreover, there is also an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and it has been observed that the global prevalence of surgical wounds was about 135,000 in 2016.
Further, the report states that one challenge in the market is uncertain regulatory approval. Cell therapy, gene therapy, and tissue engineering have been under development for several decades. However, their successful clinical application is still considered to be a recent phenomenon in both developed and developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global regenerative medicine market: ALLERGAN, Integra LifeSciences, Medtronic, MiMedx Group, Organogenesis, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “One trend in the market is emerging technological advances. With the growing demand, vendors in the stem cell therapy market focus on investing in technological advancements such as using regenerated tracheas for transplant and 3D bioprinting to survive in this competitive market.”
According to the report, one driver in the market is increasing prevalence of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US had one of more chronic health conditions in 2012. Moreover, there is also an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and it has been observed that the global prevalence of surgical wounds was about 135,000 in 2016.
Further, the report states that one challenge in the market is uncertain regulatory approval. Cell therapy, gene therapy, and tissue engineering have been under development for several decades. However, their successful clinical application is still considered to be a recent phenomenon in both developed and developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- ALLERGAN
- Integra LifeSciences
- Medtronic
- MiMedx Group
- Organogenesis
- Zimmer Biomet
Note: Product cover images may vary from those shown
